Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Lab Spotlight Exceptional Researchers and LI-COR Imaging Systems Driving Results Spotlight on Dr. Andreas von Knethen Dr. Andreas von Knethen is a Postdoctoral Fellow in the Institute of Biochemistry at Johann Wolfgang Goethe-University in Frankfurt, Germany. His research focuses on immune paralysis, tumor “Not only are the biology, inflammation, and EMSAs easier, behypoxia. cent electrophoretic mobility shift One of the main focuses in Dr von Quantitative Western blots are also Knethen’s lab is apoptosis of T cells. “In sepsis, you have two phases. The first one is the hyper-inflammatory phase, which is characterized by the release of pro-inflammatory cytokines and other pro-inflammatory markers. The second is the hypo-inflammatory phase. This phase is also called immune paralysis because the immune-competent cells are decreased cause you don’t have to radioactively label anything, but also the Western blots can be saved for years because there is no chemiluminescence that is decreasing after thirty minutes.” - Dr. Andreas von Knethen You just run the gel and put it onto the Odyssey, and you can see the DNA binding of the proteins. You don’t need to dry the gel and there is no radioactivity.” useful. Dr. von Knethen uses the Odyssey to analyze protein phosphorylation with two-color Westerns. “You can use the red and green colors together to see the total amount of protein and the phosphorylation, to analyze both of them on the same blot.” For gene knockdown studies, he uses Odyssey Westerns to monitor protein levels. He considers it the mRNA is down-regulated.” sepsis are associated with T cell apop- cell apoptosis during sepsis. Fluores- makes the assays “much more easy. protein is really gone, and not only leading to immune paralysis during transcription factor responsible for T with IRDye® 700 or IRDye 800, which the Western blot just to prove that the second or new infection. Mechanisms LI-COR Odyssey® to analyze PPARγ, a nucleotides are fluorescently labeled at the protein level. “You have to do not able to answer adequately to a Dr. von Knethen’s group uses the binding of PPARγ to DNA. The oligo- very important to confirm knockdown or inactivated and then the body is tosis, and lead to depletion of T cells.” assays (EMSA) are used to examine LINKS For more information about Dr. von Knethen’s research, visit the link below: http://www.pathobiochemie1.de/research/index.php He feels that the Odyssey makes things easier in the We thank Dr von Knethen for his contributions in bio- lab. “Not only are the EMSAs easier, because you medical research, and are proud to consider him an Odyssey Expert. don’t have to radioactively label anything, but also the Western blots can be saved for years because there is no chemiluminescence that is decreasing after thirty minutes.” PUBLICATIONS Publications resulting from work on the Odyssey: 1. von Knethen A, Neb H, Morbitzer V, Schmidt MV, Kuhn AM, Kuchler L, Brüne B. (2011) PPARgamma stabilizes HO-1 mRNA in monocytes/ macrophages which affects IFN-beta expression. Free Rad Biol Med, 51:396-405. 2. Kuhn AM, Tzieply N, Schmidt MV, von Knethen A, Namgaladze D, Yamamoto M, Brüne B. (2011) Antioxidant signaling via Nrf2 counteracts lipopolysaccharide-mediated inflammatory responses in foam cell macrophages. Free Rad Biol Med, 50:1382-1391. 3. Schmidt MV, Paulus P, Kuhn AM, Weigert A, Morbitzer V, Zacharowski K, Kempf V, Brüne B, von Knethen A. (2011) PPARgammainduced T-cell apoptosis reduces survival during polymicrobial sepsis. Am J Res Crit Care Med, 184:64-74. 4. Barra V, Kuhn AM, von Knethen A, Weigert A, Brüne B. (2011) Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/CREB. Cell Mol Life Sci, 68:1815-1817. 5. Weigert A, Cremer S, Schmidt MV, vvon Knethen A, Angioni C, Geisslinger G, Brüne B (2010) Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells. Blood, 115:3531-3540. 6. Jennewein C, von Knethen A, Schmid T, Brüne B (2010) MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor gamma (PPARgamma) mRNA de-stabilization. J Biol Chem, 285:11846-11853. 7. Namgaladze D, Morbitzer D, von Knethen A, Brüne B (2010) Phospholipase A2-modified low-density lipoprotein activates macrophages peroxisome proliferators-activated receptors. Arterioscler Thromb Vasc Biol, 30:313-320. 8. von Knethen A, Tzieply N, Jennewein C, Brüne B (2010) Casein kinase-II-dependent phosphorylation of PPARgamma at Ser16 and Ser21 provokes CRM1-mediated shuttling of PPARgamma from the nucleus to the cytosol. J Cell Sci, 163:192-201. 9. Namgaladze D, Jennewein C, Preiss S, von Knethen A, Brüne B (2009) Attenuated suppression of the oxidative burst by cells dying in the presence of oxidized low density lipoprotein. J Lipid Res, 50:2173-81. 10. Weis N, Weigert A, von Knethen A, Brüne B (2009) Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol Biol Cell, 20:1280-8. 11. Jennewein C, Kuhn AM, Schmidt MV, Meilladec-Jullig V, von Knethen A, Gonzalez FJ, Brüne B (2008) Sumoylation of PPARgamma by apoptotic cells prevents LPS-induced NCoR removal from kappaB binding sites mediating transrepression of proinflammatory cytokines. J Immunol, 181:5646-52. 12. von Knethen A, Soller M, Tzieply N, Weigert A, Johann AM, Köhl R, Brüne B (2007) PPARgamma attenuates cytosol to membrane translocation of PKCalpha to desensitize monocytes/ macrophages. J Cell Biol, 176:681-694. 4647 Superior St. • P.O. Box 4000 • Lincoln, Nebraska 68504 USA North America: 800-645-4267 • International: 402-467-0700 • FAX: 402-467-0819 LI-COR GmbH (Germany, Austria, Switzerland, Czech Republic, Hungary, and Slovakia): +49 (0) 6172 17 17 771 • LI-COR UK Ltd.: +44 (0) 1223 422104 • www.licor.com LI-COR Odyssey trademarks or LI-COR is is an an ISO ISO 9001 9001 registered registeredcompany. company. © © 2011 2007LI-COR LI-CORInc. Inc.Specifications Specificationssubject subjectto tochange. change.LI-COR, LI-COR,IRDye, Aerius,and Odyssey andare IRDye are registered trademarks of registered trademarks of LI-COR, Inc. All other trademarks toThe theirAerius respective owners. LI-COR, Inc. All other trademarks belong to their respecivebelong owners. Automated Infrared Imager, Odyssey Infrared Imager, and IRDye reagent products are covered by U.S. patents, foreign equivalents, and other patents pending. 0711 1207 982-12318 982-09493